Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Brain Injuries D001930 4 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Osteonecrosis D010020 5 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Gastritis D005756 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Satoh K et al. [Endothelial injury as an initiating factor: vascular endothelial cell injury and biosynthesis of PAF]. 1988 Nippon Rinsho pmid:3404682
Hattori A et al. [Platelets-morphology, shape changing factor, and platelet agglutinating factor. TTP Research Group]. 1993 Nippon Rinsho pmid:8433504
Yamazaki H [Recent medical topics on platelets in hemorrhagic and thrombotic diseases]. 1986 Nippon Naika Gakkai Zasshi pmid:3027214
Itoh M and Takeuchi T [Mechanism of the formation of ischemic gastric injury induced by oxygen radicals in rats]. 1990 Nippon Naika Gakkai Zasshi pmid:2175336
Ogiwara T and Sato N [Stress and etiology of peptic ulcers]. 1995 Nippon Naika Gakkai Zasshi pmid:7658116
Kawatake H and Kawakami Y [Pulmonary thromboembolism and IgE]. 1993 Nippon Naika Gakkai Zasshi pmid:8360566
Yamazaki H [Diagnostic procedure of thrombosis]. 1991 Nippon Naika Gakkai Zasshi pmid:1919199
Yano S [Drug therapy of asthma by antiallergic agents]. 1992 Nippon Naika Gakkai Zasshi pmid:1383362
Ozaki Y et al. Potentiation of neutrophil biosynthesis of platelet-activating factor by cytochalasin B: evaluation of acetyltransferase activity. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3687329
Ozaki Y et al. Acetyltransferase activity and production of platelet-activating factor by human neutrophils activated with various stimuli. 1989 Nippon Ketsueki Gakkai Zasshi pmid:2515707
Satoh K and Takamatsu S [Inactivation by plasma of platelet-activating factor]. 1986 Nippon Ketsueki Gakkai Zasshi pmid:3766067
Narita S et al. [Effects of anti-PAF agents on nasal response after allergen challenge in guinea pigs]. 1992 Nippon Jibiinkoka Gakkai Kaiho pmid:1357119
Shirasaki H and Asakura K [Effect of platelet-activating factor on nasal vascular permeability and eosinophil accumulation in guinea pigs]. 1990 Nippon Jibiinkoka Gakkai Kaiho pmid:2376799
Shirasaki H and Asakura K [Detection of platelet-activating factor in nasal lavage fluid from patients with pollinosis and experimental animals with nasal allergy]. 1990 Nippon Jibiinkoka Gakkai Kaiho pmid:2352050
Ohtani N and Asano G [Purification and partial characterization of a novel human platelet aggregation factor in the extracellular products of Streptococcus mitis, strain Nm-65]. 1996 Nippon Ika Daigaku Zasshi pmid:8987363
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Kioka K et al. [Changes in production of platelet activating factor by adherent hepatocytes of mice with experimental liver failure]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2770018
Katoh N et al. [Evaluation of the mechanism of endothelin-induced rat gastric mucosal lesion formation]. 1994 Nihon Shokakibyo Gakkai Zasshi pmid:8309086
Maeda Y [Study of acute gastric mucosal lesion induced by endotoxemia]. 1990 Nihon Shokakibyo Gakkai Zasshi pmid:2214276
Idei H et al. [Role of platelet activating factor on the formation of ischemic colitis]. 1995 Nihon Shokakibyo Gakkai Zasshi pmid:7474465
Nogami M et al. [Effects of a PAF antagonist CV-3988 on the acute gastric erosions of rats by water-immersion stress]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3404759
Boku S [A role of platelet activating factor in experimental hemorrhagic enteritis induced by Clostridium difficile toxin]. 1994 Nihon Shokakibyo Gakkai Zasshi pmid:7933638
Iwai A et al. [Role of PAF for the formation of gastric mucosal injury induced by ischemia-reinfusion in the rat]. 1990 Nihon Shokakibyo Gakkai Zasshi pmid:2232300
Nogami M et al. [Effects of a platelet activating factor (PAF) antagonist CV-3988 on acute gastric erosions in rats by water immersion and restrained stress, and by ethanol]. 1988 Nihon Shokakibyo Gakkai Zasshi pmid:3210345
Yoshikawa T et al. [Role of polymorphonuclear leukocytes and oxygen-derived free radicals in the formation of gastric mucosal lesions induced by platelet-activating factor]. 1989 Nihon Shokakibyo Gakkai Zasshi pmid:2547098
Kume K et al. [Study of platelet activating factor by using mouse ontogenic technology]. 1996 Nihon Rinsho Meneki Gakkai Kaishi pmid:9081720
Matsumoto K et al. [Platelet activating factor and tumor necrosis factor-alpha in bronchoalveolar lavage fluid of patients with ARDS]. 1993 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8315901
Shimura S et al. [Airway hyperresponsiveness and mucus secretion]. 1990 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1703251
Shimizu T [Platelet-activating factor-from molecular biology to clinic]. 1994 Nihon Kyobu Shikkan Gakkai Zasshi pmid:7602849
Yasugahira H et al. [The changes of blood gas analysis values and platelet aggregability on acute phase in the experimental model of pulmonary embolism prepared by sephadex G-75 (SG-75) injection]. 1996 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8810754
Makino S [Features and treatment of immediate and late asthmatic responses]. 1992 Nihon Kyobu Shikkan Gakkai Zasshi pmid:1447838
Tsukagoshi H et al. [Bronchial hyperresponsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor]. 1990 Nihon Kyobu Shikkan Gakkai Zasshi pmid:2290229
Tsukagoshi H and Kurosawa M [Effect of Asthremedin on bronchial hyperresponsiveness (BHR) to histamine induced by intravenous administration of platelet activating factor (PAF) in guinea pigs]. 1993 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8391092
Ono S et al. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)]. 1994 Nihon Kyobu Shikkan Gakkai Zasshi pmid:8084100
Ono S et al. [Possible involvement of vascular endothelium-derived relaxing factor induced by platelet-activating factor (PAF) on human pulmonary artery after contraction in vitro]. 1989 Nihon Kyobu Shikkan Gakkai Zasshi pmid:2615107
Shimizu K et al. [Actions of platelet activating factor in pulmonary circulation--experimental investigation using rabbit blood vessel smooth muscle preparations]. 1987 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3444152
Misawa M and Takata T [Effects of platelet activating factor on the bronchial musculature and vasculature in dogs]. 1988 Nihon Kyobu Shikkan Gakkai Zasshi pmid:3241511
Inui K [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass]. 1993 Nihon Kyobu Geka Gakkai Zasshi pmid:8473789
Masugi F et al. [Kidney medulla and hypertension, with special reference to antihypertensive lipids]. 1983 Nihon Jinzo Gakkai Shi pmid:6663856
Komatsu H et al. Platelet-activating factor induces cell growth through tyrosine phosphorylation pathway in cultured rat mesangial cells. 1995 Nihon Jinzo Gakkai Shi pmid:8583698
Suzuki S et al. [Effect of a specific antagonist of platelet-activating factor, FR-900452, on proteinuria and urinary thromboxane excretion in aminonucleoside nephrotic rats]. 1988 Nihon Jinzo Gakkai Shi pmid:3244194
Hirano T and Manabe T "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. 1992 Nihon Geka Hokan pmid:1306981
Fukuoka T [An experimental study on shock after temporary hepatic inflow occlusion and platelet activating factor (PAF)]. 1990 Nihon Geka Gakkai Zasshi pmid:2263243
Fukuoka T et al. [Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver]. 1992 Nihon Geka Gakkai Zasshi pmid:1287460
Fukuoka T et al. [Effect of a platelet activating factor (PAF) antagonist on the hepatic afferent vascular occlusion]. 1988 Nihon Geka Gakkai Zasshi pmid:3412312
Onuki Y et al. [Experimental studies on the relation of platelet activating factor (PAF) to high mortality in sublethal endotoxemia after massive hepatectomy and effects of its antagonist]. 1993 Nihon Geka Gakkai Zasshi pmid:8332121
Ono S [Clinical and experimental studies of septic DIC in surgical patients, in terms of its characteristic features and pathogenesis]. 1994 Nihon Geka Gakkai Zasshi pmid:7877583
Koltai M et al. Platelet-activating factor in septic shock. 1993 New Horiz pmid:7922397
Ayala A and Chaudry IH Platelet activating factor and its role in trauma, shock, and sepsis. 1996 New Horiz pmid:8774801
Szabó C Alterations in nitric oxide production in various forms of circulatory shock. 1995 New Horiz pmid:7535648
Christman BW and Bernard GR Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome. 1993 New Horiz pmid:8087582
Jean WC et al. Reperfusion injury after focal cerebral ischemia: the role of inflammation and the therapeutic horizon. 1998 Neurosurgery pmid:9848853
Green PG et al. Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters. 1993 Neuroscience pmid:8095706
Grassi S et al. Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 1999 Neuroscience pmid:10579215
Grassi S and Pettorossi VE Role of nitric oxide in long-term potentiation of the rat medial vestibular nuclei. 2000 Neuroscience pmid:11068144
Tabarés-Seisdedos R et al. Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study. 2006 Neuroscience pmid:16549273
Green PG et al. Further substantiation of a significant role for the sympathetic nervous system in inflammation. 1993 Neuroscience pmid:8232896
Green PG et al. Neurogenic and non-neurogenic mechanisms of plasma extravasation in the rat. 1993 Neuroscience pmid:8450970
Yue TL et al. Characterization of platelet-activating factor-induced elevation of cytosolic free-calcium level in neurohybrid NCB-20 cells. 1991 Neuroscience pmid:2057061
Moriguchi S et al. Platelet-activating factor-induced synaptic facilitation is associated with increased calcium/calmodulin-dependent protein kinase II, protein kinase C and extracellular signal-regulated kinase activities in the rat hippocampal CA1 region. 2010 Neuroscience pmid:20074623
Catalán RE et al. Platelet-activating factor inhibits (Na+,K+) ATPase activity in rat brain. 1994 Neurosci. Res. pmid:8008253
Boetkjaer A et al. Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells. 2007 Neurosci. Lett. pmid:17881124
Ezoulin MJ et al. Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells. 2005 Neurosci. Lett. pmid:16095823
Lalouette F et al. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells. 1995 Neurosci. Lett. pmid:7777190
Lustig HS et al. Comparative neurotoxic potential of glutamate, endothelins, and platelet-activating factor in cerebral cortical cultures. 1992 Neurosci. Lett. pmid:1357601
Brodie C Platelet activating factor induces nerve growth factor production by rat astrocytes. 1995 Neurosci. Lett. pmid:7783948
Giménez R and Aguilar J Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. 2001 Neurosci. Lett. pmid:11165772
Green PG et al. Trypsin enhances sympathetic neuron-dependent plasma extravasation in the rat knee joint. 1993 Neurosci. Lett. pmid:8233065
Tabuchi S et al. Lipid mediators modulate NMDA receptor currents in a Xenopus oocyte expression system. 1997 Neurosci. Lett. pmid:9406868
Liu T et al. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. 1993 Neurosci. Lett. pmid:8152586
Teather LA and Wurtman RJ Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes. 2003 Neurosci. Lett. pmid:12672535
Reiner B et al. Platelet-activating factor attenuation of long-term potentiation in rat hippocampal slices via protein tyrosine kinase signaling. 2016 Neurosci. Lett. pmid:26808643
Jiang ZG et al. Platelet-activating factor inhibits excitatory transmission in rat neostriatum. 1993 Neurosci. Lett. pmid:8104322
Kushikata T et al. Platelet activating factor and its metabolite promote sleep in rabbits. 2006 Neurosci. Lett. pmid:16263215
Kolko M et al. Neuronal damage by secretory phospholipase A2: modulation by cytosolic phospholipase A2, platelet-activating factor, and cyclooxygenase-2 in neuronal cells in culture. 2003 Neurosci. Lett. pmid:12566178
Adachi T et al. PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. 1997 Neurosci. Lett. pmid:9406887
Liu WC et al. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. 2007 Neurosci Bull pmid:17952135
Mazereeuw G et al. Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration. 2013 Neurosci Biobehav Rev pmid:23800745
Lo EJ et al. Bradykinin-induced neurogenic migration of neutrophils into the rat knee joint. 1999 Neuroreport pmid:10716216
Chen C and Bazan NG Platelet-activating factor inhibits ionotropic GABA receptor activity in cultured hippocampal neurons. 1999 Neuroreport pmid:10716218
Hostettler ME and Carlson SL PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. 2002 Neuroreport pmid:11924887
Clark GD et al. Lipids as axon guidance molecules? 1995 Neuroreport pmid:8741737
Clark GD et al. Platelet-activating factor produces neuronal growth cone collapse. 1995 Neuroreport pmid:8741765
Tran KC et al. Induction of angiogenesis by platelet-activating factor in the rat striatum. 2005 Neuroreport pmid:16148749
Zabøocka B and Domańska-Janik K PAF antagonist, BN52021, inhibits [3H]D-aspartate release after ischaemia in vitro. 1994 Neuroreport pmid:7703435
Xu Y and Tao YX Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. 2004 Neuroreport pmid:15076749
Bate C et al. The role of platelet activating factor in prion and amyloid-beta neurotoxicity. 2004 Neuroreport pmid:15094513
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Bate C et al. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. 2006 Neuropharmacology pmid:16678220
Gleason MM et al. Comparison of endothelin binding and calcium mobilization in C6-BU-1 rat glioma and N18TG2 mouse neuroblastoma cells. 1991 Neuropeptides pmid:1654531
Di Marzo V et al. Neuropeptides and leukotriene biosynthesis: the effect of calcitonin, peptide histidine valine-42, helodermin, neuropeptide Y and galanin. 1988 May-Jun Neuropeptides pmid:2458537
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537
Denizot Y et al. Platelet-activating factor and human meningiomas. 2006 Neuropathol. Appl. Neurobiol. pmid:17083481
Clark GD et al. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. 1992 Neuron pmid:1334422
Tarricone C et al. Coupling PAF signaling to dynein regulation: structure of LIS1 in complex with PAF-acetylhydrolase. 2004 Neuron pmid:15572112
Bito H et al. Platelet-activating factor (PAF) receptor in rat brain: PAF mobilizes intracellular Ca2+ in hippocampal neurons. 1992 Neuron pmid:1323312
Wieraszko A et al. Long-term potentiation in the hippocampus induced by platelet-activating factor. 1993 Neuron pmid:8461142
Schifitto G et al. Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium. 1999 Neurology pmid:10430432
Odawara M et al. Ginkgo biloba. 1997 Neurology pmid:9065574
Adunsky A et al. Infarct volume, neurological severity and PAF binding to platelets of patients with acute cerebral ischemic stroke. 1999 Neurol. Res. pmid:10555184